These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29600738)

  • 1. Under-utilization of statin medications in patients with peripheral artery disease or cerebrovascular disease.
    Armstrong EJ; Waldo SW
    Vasc Med; 2018 Jun; 23(3):241-242. PubMed ID: 29600738
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.
    McBride CL; Akeroyd JM; Ramsey DJ; Nambi V; Nasir K; Michos ED; Bush RL; Jneid H; Morris PB; Bittner VA; Ballantyne CM; Petersen LA; Virani SS
    Vasc Med; 2018 Jun; 23(3):232-240. PubMed ID: 29600737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of statins, beyond lipid-lowering properties.
    Mihos CG; Pineda AM; Santana O
    Pharmacol Res; 2014 Oct; 88():12-9. PubMed ID: 24631782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin therapy--Part II: Clinical considerations for cardiovascular disease.
    Sadowitz B; Seymour K; Costanza MJ; Gahtan V
    Vasc Endovascular Surg; 2010 Aug; 44(6):421-33. PubMed ID: 20547576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease.
    Hira RS; Cowart JB; Akeroyd JM; Ramsey DJ; Pokharel Y; Nambi V; Jneid H; Deswal A; Denktas A; Taylor A; Nasir K; Ballantyne CM; Petersen LA; Virani SS
    Am J Cardiol; 2016 Oct; 118(8):1144-1149. PubMed ID: 27553104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
    Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
    Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
    Subherwal S; Patel MR; Kober L; Peterson ED; Jones WS; Gislason GH; Berger J; Torp-Pedersen C; Fosbol EL
    Circulation; 2012 Sep; 126(11):1345-54. PubMed ID: 22874581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of statins in atherosclerotic peripheral arterial disease].
    Mendes Pedro L
    Rev Port Cardiol; 2011 Jul; 30(7-8):665-73. PubMed ID: 22005310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and peripheral arterial disease.
    Markel A
    Int Angiol; 2015 Oct; 34(5):416-27. PubMed ID: 25410295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based analysis of peripheral arterial disease screening based on the WHO criteria.
    Shah S; Antoniou GA; Torella F
    Int Angiol; 2017 Aug; 36(4):299-305. PubMed ID: 26344513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and noncardiac vascular disease.
    Paraskevas KI; Wierzbicki AS; Mikhailidis DP
    Curr Opin Cardiol; 2012 Jul; 27(4):392-7. PubMed ID: 22525327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of statins in lower extremity artery disease: a review.
    Gargiulo G; Giugliano G; Brevetti L; Sannino A; Schiattarella GG; Serino F; Carbone A; Scudiero F; Ferrone M; Corrado R; Izzo R; Chiariotti L; Perrino C; Amato B; Trimarco B; Esposito G
    BMC Surg; 2012; 12 Suppl 1(Suppl 1):S15. PubMed ID: 23173874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of lipid management in patients with coronary versus peripheral arterial disease.
    Sharma S; Thapa R; Jeevanantham V; Myers T; Hu C; Brimacombe M; Vacek JL; Dawn B; Gupta K
    Am J Cardiol; 2014 Apr; 113(8):1320-5. PubMed ID: 24560066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular disease. Beneficial statins underused in PAD.
    Roberts A
    Nat Rev Cardiol; 2014 May; 11(5):249. PubMed ID: 24642646
    [No Abstract]   [Full Text] [Related]  

  • 15. Have statins changed the natural history of atheromatous disease and its treatment?
    Samson RH
    Semin Vasc Surg; 2008 Sep; 21(3):160-4. PubMed ID: 18774452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.
    Cea-Soriano L; Fowkes FGR; Johansson S; Allum AM; García Rodriguez LA
    BMJ Open; 2018 Jan; 8(1):e018184. PubMed ID: 29358428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resource use and costs in high-risk symptomatic peripheral artery disease patients with diabetes and prior acute coronary syndrome: a retrospective analysis.
    Reed Chase M; Friedman HS; Navaratnam P; Heithoff K; Simpson RJ
    Postgrad Med; 2016; 128(2):170-9. PubMed ID: 26788980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of statins with aortic, peripheral, and visceral artery aneurysm development.
    Mansi IA; Frei CR; Halm EA; Mortensen EM
    Vascular; 2017 Aug; 25(4):372-381. PubMed ID: 28264180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strengthening the role of statin therapy in atherosclerosis for the prevention and treatment of cerebrovascular disease].
    Liu LP; Wang YJ
    Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):275-7. PubMed ID: 21600141
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
    Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.